Expand Content

Sean Lyden, MD


Sean Lyden, MD
Department: Vascular Surgery
Location: Cleveland Clinic Main Campus
Mail Code H32
9500 Euclid Avenue
Cleveland, OH 44195
Sean Lyden, MD
Department: Medical Operations
Medical Director, Clinical Supply Chain Management
Location: Cleveland Clinic Main Campus
Mail Code H32
9500 Euclid Avenue
Cleveland, OH 44195
Type of Doctor:
Adults Only

Biographical Sketch

Sean Lyden, MD, is a vascular surgeon in the Department of Vascular Surgery, Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic.  He has interests in abdominal aortic aneurysms, carotid artery disease, and lower-extremity endovascular treatments.

A native of Youngstown, Ohio, Dr. Lyden earned his medical degree from the University of Cincinnati College of Medicine following an undergraduate degree from the University of Notre Dame. He served a residency in general surgery at the University of Tennessee Health Sciences Center in Memphis where he was inducted into the Alpha Omega Alpha Medical Honor Society.  His training included a year doing trauma research.   He subsequently served a fellowship in vascular surgery at the University of Rochester-Strong Memorial Hospital, Rochester, NY.

Dr. Lyden was appointed to the Cleveland Clinic staff in 2001. He is an Associate Professor in the Division of Vascular Surgery at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

He currently is involved in more than 16 clinical trials studying various topics including thoracic, fenestrated and abdominal stent grafting; lower extremity interventional therapies with atherectomy and drug coated balloons; carotid stenting; and deep venous thrombosis treatments.  Dr. Lyden has presented his research and clinical findings at more than 80 national and international medical symposia and conferences.

He serves on the editorial boards of Endovascular Today and Annals of Vascular Surgery and serves as reviewer for several journals, including the Journal of Vascular Surgery, Annals of Vascular Surgery and the Journal of the American College of Surgeons. He has authored and co-authored over 60 articles in leading publications, including the Journal of Vascular Surgery, Vascular Medicine and Journal of Endovascular Therapy. He also has also authored chapters in several vascular textbooks.

Dr. Lyden is a Fellow of the American College of Surgeons and has been recognized as a Distinguished Fellow of the Society for Vascular Surgery.  He is also a member of many regional vascular societies including the Peripheral Vascular Surgical Society, the Society for Clinical Vascular Surgery, the International Society for Endovascular Specialists and the Midwestern Vascular Surgical Society.

Education & Fellowships

Fellowship - University of Rochester-Strong Memorial Hospital
Vascular Surgery
Rochester, NY USA
Residency - University of Tennessee Health Sciences Center
General Surgery
Memphis, TN USA
Internship - University of Tennessee Health Sciences Center
Memphis, TN USA
Medical School - University of Cincinnati College of Medicine
Cincinnati, OH USA
Undergraduate - University of Notre Dame
Notre Dame, IN USA


  • Surgery
  • Surgery- Vascular Surgery

Specialty Interests

Aortic aneurysms, carotid artery disease, aorta surgery, high risk reoperation surgery, surgery for peripheral arterial disease (PAD)


  • Faculty, American College of Surgeons
  • Society for Vascular Surgery
  • Peripheral Vascular Surgery Society
  • Midwestern Vascular Surgery Society
  • International Society for Vascular Surgery

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/11/2014, Dr. Lyden has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Lyden receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Cook Group Incorporated
  • Covidien plc.
  • TriVascular, Inc.
  • VIVA Physicians

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English